Overview

Stage I/II Nasal NK Cell Lymphoma

Status:
Terminated

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to learn if radiation therapy and chemotherapy can help control stage 1 and/or 2 NK cell lymphoma. The safety of radiation and chemotherapy will also be studied.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Treatments:

Cyclophosphamide
Doxorubicin
Liposomal doxorubicin
Prednisone
Vincristine